Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.92 [0.9-0.95],1.4717888269828e-06,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.07 [1.04-1.1],1.28729048313604e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FCRL1,Fc receptor-like protein 1,Inverse variance weighted,19,1.08 [1.04-1.12],2.00197896353366e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.11 [1.05-1.17],9.21161742570694e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.13 [1.06-1.2],0.000125882217440247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.07 [1.03-1.11],0.000668609955773383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.11 [1.04-1.18],0.0015411358148847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PALM2,Paralemmin-2,Inverse variance weighted,8,1.09 [1.03-1.16],0.00171016603702345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.1 [1.03-1.16],0.00199082583488468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.16 [1.05-1.28],0.00275829764601036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSS,Cathepsin S,Inverse variance weighted,23,1.05 [1.02-1.08],0.00348929374486974,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.7 [0.55-0.89],0.00442539566844071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD302,CD302 antigen,Inverse variance weighted,9,0.94 [0.9-0.98],0.00469824254252407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.25 [1.07-1.47],0.00578522411907111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AGRN,Agrin,Inverse variance weighted,17,0.95 [0.91-0.99],0.0107036192085725,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COLEC12,Collectin-12,Inverse variance weighted,11,0.94 [0.89-0.99],0.0112659246380846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,19,1.04 [1.01-1.08],0.0116331211082873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.92 [0.87-0.98],0.0118606025921681,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.07 [1.01-1.12],0.0120540534655853,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.93 [0.88-0.98],0.0120736051188049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.89 [0.81-0.98],0.013054198100509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.16 [1.03-1.31],0.0150766064552107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.96 [0.93-0.99],0.0184106549332748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.04 [1.01-1.07],0.02162208369213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,1.1 [1.01-1.19],0.0216450576164395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.14 [1.02-1.28],0.0228149638903232,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.96 [0.92-0.99],0.0243765025645919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,0.95 [0.92-0.99],0.0254025918324919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,1.2 [1.02-1.41],0.0279076793742943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,0.95 [0.9-0.99],0.0283948710906285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.07 [1.01-1.14],0.0302528016377636,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.04 [1-1.08],0.0303384057874251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPP1,Osteopontin,Inverse variance weighted,8,0.9 [0.83-0.99],0.0305999973871292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.08 [1.01-1.16],0.0321005662862167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,OGN,Mimecan,Inverse variance weighted,30,0.97 [0.94-1],0.0354693278676265,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NUCB2,Nucleobindin-2,Inverse variance weighted,24,0.97 [0.94-1],0.0367670677271036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.1 [1.01-1.2],0.0369070591405886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.03 [1-1.06],0.0411835772117494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.85 [0.73-1],0.0448702292278411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.02 [1-1.04],0.0456373985480805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RSPO3,R-spondin-3,Inverse variance weighted,6,0.93 [0.87-1],0.0472758669629326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1.06 [1-1.11],0.0482578710726963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.02 [1-1.05],0.0488101631505832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS3,Galectin-3,Inverse variance weighted,25,0.97 [0.95-1],0.0501035004362749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.96 [0.91-1],0.052370645320271,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.97 [0.95-1],0.052544536249472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.88 [0.78-1],0.0551516077531122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.96 [0.92-1],0.0560920594771264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.08 [1-1.16],0.0568960878999708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.79 [0.62-1.01],0.0581311857816089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.96-1],0.0585676819641892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.82 [0.67-1.01],0.0621681671023291,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.75 [0.56-1.02],0.0631433846398341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.73 [0.51-1.03],0.0715814257519175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.04 [1-1.08],0.0737532875997207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.95 [0.9-1],0.0743288929806679,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAYN,Layilin,Inverse variance weighted,20,0.96 [0.91-1],0.0744524491566554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.97 [0.94-1],0.0788964279589342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.95 [0.89-1.01],0.0867419580005943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.07 [0.99-1.15],0.0880651959910357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RSPO1,R-spondin-1,Inverse variance weighted,5,1.07 [0.99-1.15],0.0904687351987628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,0.95 [0.91-1.01],0.0920499101981845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.28 [0.96-1.7],0.0941048739702752,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.96 [0.93-1.01],0.094459212343451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.97 [0.93-1.01],0.0952396335337076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.95 [0.89-1.01],0.0958835080506581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.06 [0.99-1.13],0.0961306377325874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.05 [0.99-1.1],0.0968755001349411,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.95 [0.89-1.01],0.0974270397640498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.02 [1-1.04],0.102468539389269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.93 [0.85-1.02],0.105361495169597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GRN,Progranulin,Inverse variance weighted,7,1.05 [0.99-1.11],0.110059707583684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.94 [0.87-1.01],0.111331766216261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.97 [0.94-1.01],0.114668374982302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.82 [0.65-1.05],0.115503430682242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.02 [0.99-1.05],0.121261692859071,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.94 [0.86-1.02],0.132835182570494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.14 [0.96-1.36],0.133058026342883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.96 [0.92-1.01],0.135623034074623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.99 [0.97-1],0.136379754189282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.05 [0.98-1.12],0.136747492127981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.96 [0.9-1.01],0.139463663784273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.97 [0.94-1.01],0.143873277610448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.28 [0.92-1.78],0.146296952046461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.96 [0.92-1.01],0.147759410376872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DPT,Dermatopontin,Inverse variance weighted,21,0.97 [0.93-1.01],0.149302237464012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PRELP,Prolargin,Inverse variance weighted,9,1.03 [0.99-1.08],0.15287889304973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,19,1.02 [0.99-1.04],0.161694075052103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PENK,Proenkephalin-A,Inverse variance weighted,19,1.02 [0.99-1.06],0.163535222214211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,40,1.01 [0.99-1.03],0.166003555848247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.06 [0.98-1.15],0.169013633610123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.02 [0.99-1.06],0.169408900335224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.97 [0.92-1.01],0.172392804686525,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,1.05 [0.98-1.13],0.173273909177023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.98 [0.95-1.01],0.173615349235457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.04 [0.98-1.09],0.187831223935342,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.95 [0.88-1.03],0.189525212379081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.95 [0.87-1.03],0.191672691307785,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.99 [0.97-1.01],0.193603498731968,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BSG,Basigin,Wald ratio,1,1.07 [0.97-1.17],0.196829452607798,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,THBD,Thrombomodulin,Inverse variance weighted,5,1.04 [0.98-1.11],0.203559521171563,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD48,CD48 antigen,Inverse variance weighted,18,1.01 [0.99-1.04],0.204631021427226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.26 [0.88-1.81],0.209061805269799,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.04 [0.98-1.11],0.211395484780743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.79 [0.55-1.14],0.212472921248373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.92 [0.82-1.05],0.21252064405502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.06 [0.97-1.15],0.216438863414981,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.93 [0.82-1.05],0.220713651911848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.95 [0.89-1.03],0.225230680905885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.97 [0.93-1.02],0.226281000501326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.09 [0.94-1.27],0.233163463191983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.97-1.01],0.233192305892601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1.06 [0.96-1.17],0.23792749097698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.97-1.01],0.244421495761418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.95 [0.87-1.04],0.245537391940759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.98 [0.95-1.01],0.251792420868152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.02 [0.99-1.06],0.25491834137114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.12 [0.92-1.36],0.256474200393028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MILR1,Allergin-1,Inverse variance weighted,33,1.01 [0.99-1.03],0.258090475151757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.01 [0.99-1.03],0.259112642844375,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.02 [0.98-1.06],0.26024722607713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.98 [0.94-1.02],0.261473447126066,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.98 [0.95-1.01],0.262718473029683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.01 [0.99-1.04],0.265754667478546,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.05 [0.96-1.14],0.266388403764744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,1.02 [0.99-1.04],0.267284831280851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NECTIN2,Nectin-2,Inverse variance weighted,5,0.97 [0.92-1.02],0.267824974308453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCN4,CCN family member 4,Inverse variance weighted,27,0.98 [0.95-1.02],0.27511566729257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.95 [0.86-1.04],0.277193972919399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.98 [0.94-1.02],0.279192009078309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.05 [0.96-1.13],0.283789286231944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.03 [0.98-1.08],0.287183802851143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CST3,Cystatin-C,Inverse variance weighted,10,1.02 [0.98-1.06],0.287484720827222,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS1,Galectin-1,Inverse variance weighted,6,0.98 [0.94-1.02],0.294049202678539,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.92 [0.78-1.08],0.2988489606967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.91 [0.77-1.09],0.30589779117303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.95 [0.86-1.05],0.309717673072545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AREG,Amphiregulin,Inverse variance weighted,3,0.96 [0.88-1.04],0.310646629207649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.02 [0.98-1.07],0.311017446317628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,0.99 [0.96-1.01],0.314564318203947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,0.98 [0.94-1.02],0.31822626165697,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,9,1.02 [0.98-1.07],0.318614463277841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.02 [0.99-1.05],0.319913752920973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,VWC2,Brorin,Inverse variance weighted,22,1.02 [0.98-1.06],0.321589375510671,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS4,Galectin-4,Inverse variance weighted,4,1.07 [0.94-1.22],0.322469557359963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.99-1.02],0.327651122559913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SCG3,Secretogranin-3,Inverse variance weighted,32,0.99 [0.96-1.01],0.328057640816428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.94 [0.84-1.06],0.330141727317406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.98 [0.94-1.02],0.337927582394884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,OCLN,Occludin,Inverse variance weighted,2,0.95 [0.86-1.05],0.341924904566514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD276,CD276 antigen,Inverse variance weighted,20,0.99 [0.96-1.01],0.344729901705549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1.02 [0.97-1.08],0.348890602510424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.06 [0.94-1.2],0.349350675817721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.98 [0.94-1.02],0.358274801739194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.02 [0.98-1.06],0.365899985304816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.91 [0.74-1.12],0.368071747319295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.19 [0.81-1.75],0.370074267909677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KLK11,Kallikrein-11,Inverse variance weighted,6,1.01 [0.99-1.04],0.371837327922441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.02 [0.98-1.06],0.377541089494535,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.03 [0.97-1.1],0.38156951270269,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.97-1.09],0.385883368955131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,0.98 [0.95-1.02],0.388679124449501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MMP7,Matrilysin,Inverse variance weighted,13,0.98 [0.95-1.02],0.392180501816462,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,0.99 [0.98-1.01],0.395706856568281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.02 [0.98-1.06],0.398144365134599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CDH6,Cadherin-6,Inverse variance weighted,29,0.99 [0.97-1.01],0.398930332739018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,12,1.02 [0.98-1.06],0.39964079800651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.04 [0.95-1.15],0.401202761927564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.93 [0.78-1.11],0.405365668955416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.95 [0.83-1.08],0.409312576977988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PSAP,Prosaposin,Inverse variance weighted,5,0.97 [0.9-1.04],0.41303679716217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.97-1.01],0.414604519892876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AMBP,Protein AMBP,Inverse variance weighted,3,0.96 [0.86-1.06],0.418620724453384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.08 [0.89-1.32],0.421550772359532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC3B,Tetranectin,Inverse variance weighted,7,1.03 [0.96-1.1],0.422720949696231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.02 [0.98-1.06],0.424588275336406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.07 [0.91-1.25],0.424718759150352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.04 [0.94-1.16],0.426914895749834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.95 [0.85-1.07],0.428053314361285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.96 [0.86-1.06],0.429695392636217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCN3,CCN family member 3,Inverse variance weighted,19,1.02 [0.97-1.07],0.429857741087512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RETN,Resistin,Inverse variance weighted,9,0.99 [0.96-1.02],0.429937067641932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPON2,Spondin-2,Inverse variance weighted,4,0.98 [0.92-1.03],0.434864331032655,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.02 [0.97-1.07],0.43609899968924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SDC1,Syndecan-1,Inverse variance weighted,2,1.04 [0.94-1.16],0.440022683763125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.99 [0.96-1.02],0.443406354425367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.96 [0.87-1.06],0.444316514011711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.98 [0.92-1.04],0.446972583413975,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,1.12 [0.83-1.5],0.453848880389797,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.01 [0.98-1.05],0.454640806643722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.96-1.08],0.454899406902069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.01 [0.99-1.02],0.459079915320231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DSC2,Desmocollin-2,Inverse variance weighted,9,0.98 [0.94-1.03],0.462358482441112,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.98 [0.92-1.04],0.463790858741204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,0.97 [0.89-1.05],0.464083059747233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,0.96 [0.87-1.07],0.47117071837455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RBP1,Retinol-binding protein 1,Wald ratio,1,0.96 [0.85-1.08],0.477698140620768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.01 [0.98-1.05],0.483878690810305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.97 [0.88-1.06],0.492987333550011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.99 [0.95-1.02],0.494348093234963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.01 [0.98-1.05],0.500192774310629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KLK4,Kallikrein-4,Inverse variance weighted,17,1.01 [0.98-1.04],0.501419260755908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MDK,Midkine,Inverse variance weighted,4,1.03 [0.94-1.13],0.504470662743281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.04 [0.92-1.18],0.522880105673565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.03 [0.94-1.12],0.527744429311311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.04 [0.93-1.15],0.533820052144244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NECTIN4,Nectin-4,Inverse variance weighted,7,0.98 [0.94-1.03],0.536162230623194,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NPPC,C-type natriuretic peptide,Wald ratio,1,0.91 [0.66-1.25],0.544003402265692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.96 [0.83-1.1],0.546444842862717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.02 [0.96-1.09],0.55038607036204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS9,Galectin-9,Inverse variance weighted,26,1.01 [0.97-1.05],0.551187345767362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.97 [0.88-1.07],0.552132030314528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.98 [0.93-1.04],0.552501689113229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REN,Renin,Inverse variance weighted,4,0.99 [0.94-1.03],0.554941749695775,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.01 [0.97-1.05],0.564624210446611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.97 [0.86-1.08],0.56568804870696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.01 [0.97-1.06],0.568208582737037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.97 [0.88-1.07],0.570413740213374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,0.98 [0.92-1.05],0.571320760005037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.99-1.02],0.575723421527812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,15,1.01 [0.97-1.06],0.578276146664298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.01 [0.96-1.07],0.583065686049456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SERPINA9,Serpin A9,Inverse variance weighted,25,1 [0.99-1.02],0.589641170948135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.99 [0.97-1.02],0.593074713327171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.02 [0.95-1.09],0.597750963407457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FBLN2,Fibulin-2,Inverse variance weighted,11,1.01 [0.96-1.07],0.598140150020012,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.12 [0.74-1.68],0.598151082533027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.01 [0.97-1.06],0.60285312169219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.98 [0.92-1.05],0.602899200518677,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSL,Cathepsin L1,Wald ratio,1,0.93 [0.69-1.24],0.60432317113508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.92 [0.68-1.25],0.606954902268827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.99 [0.96-1.02],0.611254705317736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.97-1.02],0.612788971368088,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TG,Thyroglobulin,Inverse variance weighted,2,1.26 [0.52-3.04],0.614142726296651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.99-1.02],0.615588367563303,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RGMB,RGM domain family member B,Inverse variance weighted,9,1.02 [0.95-1.09],0.621637774718576,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.03 [0.93-1.13],0.621759881473892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.02 [0.94-1.11],0.627539052821433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ALCAM,CD166 antigen,Inverse variance weighted,6,1.02 [0.94-1.11],0.631113725830035,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.01 [0.97-1.06],0.637866680307484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PGF,Placenta growth factor,Inverse variance weighted,2,0.85 [0.44-1.66],0.641629618125687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.01 [0.97-1.06],0.646364524726457,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSO,Cathepsin O,Inverse variance weighted,6,0.99 [0.93-1.05],0.650132953032085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MMP3,Stromelysin-1,Inverse variance weighted,34,0.99 [0.97-1.02],0.653198658468321,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.03 [0.92-1.14],0.657661984894978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.02 [0.94-1.1],0.666346503139847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.01 [0.95-1.09],0.671234293789943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PRND,Prion-like protein doppel,Inverse variance weighted,9,0.99 [0.96-1.03],0.675733891232949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.97 [0.84-1.12],0.676333346993183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.94 [0.69-1.28],0.678307921140676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTN,Pleiotrophin,Inverse variance weighted,4,0.97 [0.82-1.14],0.67844214523748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.99 [0.95-1.03],0.690031553158542,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1 [0.98-1.03],0.69592347796849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.04 [0.86-1.24],0.699074670912465,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1.01 [0.98-1.04],0.699344652556683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.97 [0.84-1.13],0.715923996808796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.99 [0.97-1.02],0.71752782861532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.99 [0.93-1.05],0.718260281544646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.97 [0.84-1.12],0.718431877011824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IFNL1,Interferon lambda-1,Wald ratio,1,1.06 [0.78-1.44],0.718546831839541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.01 [0.95-1.07],0.722794007667396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ELN,Elastin,Inverse variance weighted,2,1.03 [0.87-1.23],0.728197889527786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.02 [0.93-1.12],0.728710550827513,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.04 [0.84-1.28],0.729966794087638,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.99 [0.96-1.03],0.730910283560389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LMNB2,Lamin-B2,Wald ratio,1,1.06 [0.76-1.47],0.734022171192737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.96-1.03],0.735916935871436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ANXA10,Annexin A10,Wald ratio,1,1.05 [0.81-1.36],0.736887034325165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.02 [0.9-1.16],0.738464105220501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.99 [0.96-1.03],0.750078351359014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCN5,CCN family member 5,Inverse variance weighted,8,1.02 [0.92-1.13],0.750092073245954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.99 [0.96-1.03],0.754863745846382,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.95 [0.7-1.3],0.754933125869512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.04 [0.81-1.33],0.75872473204936,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.04 [0.8-1.35],0.761961468114407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.01 [0.93-1.11],0.769325614736427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1 [0.98-1.03],0.774544915566626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,0.98 [0.83-1.15],0.776066997953244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,18,0.99 [0.94-1.05],0.777244636177381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,1.01 [0.96-1.06],0.780369765152458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.99 [0.96-1.03],0.781470715074898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,1.01 [0.96-1.05],0.78316118445885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1 [0.97-1.02],0.786487497879769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,1.01 [0.96-1.06],0.787784369176925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,16,1.01 [0.96-1.05],0.789954329308536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,XCL1,Lymphotactin,Inverse variance weighted,31,1 [0.97-1.03],0.793115860319803,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.96 [0.73-1.27],0.795528370624168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.01 [0.95-1.07],0.796795488276886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD22,B-cell receptor CD22,Inverse variance weighted,6,0.99 [0.95-1.04],0.808168819006996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1 [0.95-1.04],0.815154270493202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.94-1.08],0.820899431635881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.99 [0.89-1.1],0.822224780249665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TCN2,Transcobalamin-2,Inverse variance weighted,34,1 [0.98-1.03],0.829054663737396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.02 [0.88-1.18],0.8298583482293,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1 [0.98-1.02],0.836058365166867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.96-1.03],0.836415180107668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1 [0.95-1.04],0.84105210034877,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1 [0.95-1.04],0.8445470445851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1 [0.95-1.04],0.850613575304897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.95 [0.56-1.62],0.854337133287918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CHGA,Chromogranin-A,Inverse variance weighted,3,1.01 [0.92-1.11],0.858955451626637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1 [0.97-1.04],0.859099933957783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.97-1.04],0.859305403696783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL10,Interleukin-10,Wald ratio,1,1.01 [0.89-1.15],0.859510538778332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.98 [0.79-1.21],0.859544785284448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,UMOD,Uromodulin,Inverse variance weighted,29,1 [0.98-1.02],0.859621853951383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.99 [0.9-1.1],0.87442167536459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.01 [0.86-1.2],0.874493420517062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.03 [0.72-1.46],0.879412947163979,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1 [0.95-1.04],0.883126787857225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1 [0.95-1.04],0.885229040857854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.01 [0.83-1.24],0.885794941702611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPO,Erythropoietin,Inverse variance weighted,5,1.01 [0.86-1.19],0.889276686733665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.01 [0.84-1.23],0.892468352923286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.99 [0.89-1.11],0.892951436188092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1 [0.97-1.03],0.899281316065336,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1 [0.98-1.02],0.89958333945538,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD83,CD83 antigen,Inverse variance weighted,5,1 [0.94-1.07],0.899639074482224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1 [0.96-1.05],0.900774441106529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.96-1.05],0.90137726506017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD46,Membrane cofactor protein,Wald ratio,1,0.99 [0.85-1.15],0.91159001918195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD59,CD59 glycoprotein,Inverse variance weighted,4,1 [0.94-1.05],0.920196642337747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DRAXIN,Draxin,Inverse variance weighted,13,1 [0.97-1.03],0.922221213971944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1 [0.92-1.08],0.9224557141384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1 [0.97-1.03],0.924581678000816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.99 [0.82-1.2],0.928831839861601,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,3,1 [0.93-1.09],0.929425955132481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1 [0.92-1.09],0.940536944197022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GUCA2A,Guanylin,Inverse variance weighted,9,1 [0.91-1.09],0.942205884661545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MPO,Myeloperoxidase,Inverse variance weighted,11,1 [0.96-1.04],0.945015766163283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FOLR2,Folate receptor beta,Inverse variance weighted,2,1 [0.9-1.12],0.948671288282402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD160,CD160 antigen,Inverse variance weighted,11,1 [0.96-1.04],0.957920652230289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1 [0.93-1.08],0.962216611341168,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1 [0.97-1.04],0.963753944431504,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1 [0.98-1.02],0.964464123672695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1 [0.97-1.03],0.966700653321714,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1 [0.86-1.16],0.97518985249142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1 [0.91-1.1],0.97923983163741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1 [0.96-1.04],0.980260516039379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,12,1 [0.98-1.02],0.986571056950527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1 [0.87-1.14],0.986609558415678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1 [0.92-1.09],0.988238457302187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1 [0.98-1.02],0.988282990108502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1 [0.96-1.04],0.992716845754406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.74 [1.6-1.89],5.18573198257796e-38,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TSHB,Thyrotropin subunit beta,Inverse variance weighted,31,1.42 [1.22-1.66],5.24416150713548e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.17 [1.08-1.26],5.93868057914677e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.06 [1.03-1.1],0.000245698710623438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.12 [1.05-1.19],0.000339344891329809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PALM2,Paralemmin-2,Inverse variance weighted,9,1.1 [1.04-1.16],0.00066876373610897,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.23 [1.08-1.41],0.0015709454949288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DRAXIN,Draxin,Inverse variance weighted,25,1.12 [1.04-1.2],0.00161656354827883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.84 [1.25-2.72],0.00214361116811794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.41 [1.12-1.78],0.00314803697039562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CDH6,Cadherin-6,Inverse variance weighted,5,1.22 [1.07-1.39],0.003608088319036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.21 [1.06-1.37],0.00410028731250296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.87 [0.79-0.96],0.00475318344836496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.09 [1.03-1.16],0.005835837765237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.09 [1.02-1.16],0.00884382451495878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.18 [1.04-1.34],0.0119174341922792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.88 [0.79-0.97],0.0126620324843836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD7,T-cell antigen CD7,Inverse variance weighted,12,1.04 [1.01-1.07],0.0133173679250161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,0.95 [0.91-0.99],0.0147146870497734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.96 [0.93-0.99],0.0167064340697166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.11 [1.02-1.21],0.0167395168869154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.24 [1.04-1.49],0.0176999836067345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.8 [0.66-0.97],0.0210797800354612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.87 [0.78-0.98],0.0215832532727568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RETN,Resistin,Inverse variance weighted,19,0.91 [0.85-0.99],0.0238966601058207,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.82 [0.69-0.98],0.028725398955591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.9 [0.82-0.99],0.0292338704447235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,12,1.13 [1.01-1.26],0.0358043226392601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.1 [1.01-1.2],0.037540835762278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD276,CD276 antigen,Inverse variance weighted,24,0.95 [0.9-1],0.0389345503304687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,OCLN,Occludin,Inverse variance weighted,2,0.82 [0.68-0.99],0.0420608515263107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.87 [0.76-1],0.0451321184716942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.05 [1-1.1],0.0483533418666817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LMNB2,Lamin-B2,Inverse variance weighted,8,1.1 [1-1.22],0.0506038695154179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD83,CD83 antigen,Inverse variance weighted,14,1.15 [1-1.32],0.0521268348981552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TG,Thyroglobulin,Inverse variance weighted,36,1.19 [1-1.43],0.0523991622928549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.13 [1-1.27],0.0530278149223277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.15 [1-1.32],0.0533941643699693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.93 [0.87-1],0.0541013367543076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.18 [1-1.41],0.0545143275892578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.9 [0.81-1],0.056625658366536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.25 [0.99-1.58],0.0588878968464111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.08 [1-1.17],0.0604631191619747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.48 [0.98-2.23],0.0619972972049267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.23 [0.99-1.53],0.0623208075701034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.15 [0.99-1.33],0.062466293408492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.94 [0.89-1],0.0644688668453767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.88 [0.76-1.01],0.0672813904870538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSO,Cathepsin O,Inverse variance weighted,19,0.95 [0.9-1],0.0688347666948199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.03 [1-1.05],0.0689721251633305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.8 [0.63-1.02],0.0693148018278359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.35 [0.98-1.87],0.0697365964705945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,6,0.89 [0.78-1.01],0.0708710175850404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.16 [0.99-1.37],0.0709027153628744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.12 [0.99-1.26],0.0718078238417223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPO,Erythropoietin,Inverse variance weighted,11,0.93 [0.87-1.01],0.0721671553191863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.13 [0.99-1.29],0.0726531710666176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,0.96 [0.92-1],0.0749234101566209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.93 [0.86-1.01],0.0776962156112196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.08 [0.99-1.18],0.0779336003164338,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.88 [0.77-1.01],0.0787199272456824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCN4,CCN family member 4,Inverse variance weighted,29,0.97 [0.94-1],0.0825181686412667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.06 [0.99-1.14],0.0910741151821935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,1.1 [0.98-1.24],0.0925506225191767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.96 [0.92-1.01],0.0951721745821961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.95 [0.89-1.01],0.0974270397640498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.88 [0.76-1.02],0.099057445162385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.32 [0.95-1.85],0.100723929635787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSS,Cathepsin S,Inverse variance weighted,7,0.92 [0.84-1.02],0.10219065394426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.9 [0.79-1.02],0.104101192958475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.34 [0.93-1.92],0.111951938241456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PRND,Prion-like protein doppel,Inverse variance weighted,15,0.94 [0.87-1.02],0.111996015115553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,XG,Glycoprotein Xg,Inverse variance weighted,2,0.84 [0.67-1.05],0.116786038151621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.02 [1-1.04],0.120506485307898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MMP7,Matrilysin,Wald ratio,1,0.91 [0.8-1.03],0.123141375983297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.05 [0.99-1.13],0.126624767284107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.06 [0.98-1.15],0.128377782949766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DSC2,Desmocollin-2,Inverse variance weighted,16,0.97 [0.93-1.01],0.128546039623237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.08 [0.98-1.2],0.128658359313563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,1.17 [0.96-1.42],0.130705478951996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.82 [0.63-1.06],0.131420138471852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.07 [0.98-1.17],0.132721431684454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.14 [0.96-1.34],0.133570023990243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.8 [0.59-1.07],0.134597017212298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS3,Galectin-3,Inverse variance weighted,15,0.95 [0.9-1.01],0.136296651427977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS4,Galectin-4,Inverse variance weighted,15,1.03 [0.99-1.06],0.143612660223734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.91 [0.81-1.03],0.14563500540599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.87 [0.73-1.05],0.147432023575726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.8 [0.6-1.08],0.147850761327607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.07 [0.98-1.17],0.150601833981813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.95 [0.88-1.02],0.150886436372805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.1 [0.97-1.25],0.150994845496767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AMBP,Protein AMBP,Inverse variance weighted,5,0.94 [0.86-1.02],0.15757355206326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.03 [0.99-1.07],0.157888685550141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,0.97 [0.92-1.01],0.161871051833233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.04 [0.98-1.1],0.163180764923842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.91 [0.8-1.04],0.168929503939545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.07 [0.97-1.17],0.169905066102081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.09 [0.96-1.22],0.172376448411844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.82 [0.6-1.1],0.181244964579851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.84 [0.66-1.08],0.183015424197884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.05 [0.98-1.12],0.186299447769761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.04 [0.98-1.1],0.187804761734813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.12 [0.95-1.32],0.188619076615036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.92 [0.81-1.04],0.189538408405264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SERPINA9,Serpin A9,Wald ratio,1,1.26 [0.89-1.77],0.189810533627055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.19 [0.91-1.55],0.195796045842251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COLEC12,Collectin-12,Inverse variance weighted,3,1.22 [0.9-1.64],0.198805496262085,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.34 [0.86-2.1],0.199820829912652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.11 [0.94-1.31],0.203749852038811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.97-1.01],0.204858098462395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.05 [0.97-1.13],0.205111181666208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.27 [0.88-1.83],0.205955215847444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.99 [0.96-1.01],0.206321050214441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.95 [0.88-1.03],0.206446589396182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.96 [0.9-1.02],0.208296866708556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,OGN,Mimecan,Inverse variance weighted,37,0.98 [0.95-1.01],0.212098773383186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MILR1,Allergin-1,Inverse variance weighted,43,1.01 [0.99-1.03],0.222477441209839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.16 [0.91-1.47],0.223019788450137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PSAP,Prosaposin,Inverse variance weighted,13,0.96 [0.9-1.03],0.226485368224964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.93 [0.83-1.05],0.234559184127931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.11 [0.93-1.32],0.234678194300873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.94 [0.86-1.04],0.237044844841157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.17 [0.9-1.52],0.237680561432932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.1 [0.94-1.29],0.237856109550635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD48,CD48 antigen,Inverse variance weighted,14,1.08 [0.95-1.24],0.239051967557377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.93 [0.83-1.05],0.239326282383101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.03 [0.98-1.09],0.241719767906222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.94 [0.84-1.05],0.24809595183783,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.96 [0.89-1.03],0.252039012203278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.07 [0.95-1.2],0.253338199896555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,0.94 [0.84-1.05],0.256363559761055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FCRL1,Fc receptor-like protein 1,Inverse variance weighted,32,1.05 [0.97-1.13],0.258863038173044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.98 [0.94-1.02],0.26519922298072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,1.1 [0.93-1.32],0.265574193957385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.16 [0.89-1.5],0.266107523568285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.06 [0.95-1.18],0.266602399457031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.96 [0.89-1.03],0.266790829112929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC3B,Tetranectin,Inverse variance weighted,2,1.26 [0.83-1.92],0.276290356618337,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.13 [0.91-1.4],0.277921739519256,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RSPO1,R-spondin-1,Inverse variance weighted,8,1.09 [0.93-1.27],0.279768401460064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPON1,Spondin-1,Inverse variance weighted,4,1.14 [0.9-1.45],0.289444741676398,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.08 [0.94-1.24],0.290944244721564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,1.07 [0.95-1.2],0.291401666094671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL10,Interleukin-10,Inverse variance weighted,4,0.95 [0.86-1.04],0.291530678275887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.07 [0.95-1.2],0.296238565256185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.96 [0.88-1.04],0.296603098027379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.9 [0.75-1.09],0.296724829980849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.96 [0.9-1.03],0.303073954224556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.12 [0.9-1.39],0.309034563705679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.04 [0.97-1.11],0.309050524747252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.05 [0.96-1.14],0.310859034593066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ELN,Elastin,Inverse variance weighted,10,1.05 [0.96-1.15],0.310971154020828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,11,1.03 [0.97-1.11],0.317846664854695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.04 [0.96-1.14],0.329339120739972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.03 [0.97-1.09],0.329777193262246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.93 [0.81-1.07],0.330999970648489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.84 [0.59-1.2],0.331437399329461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.99-1.02],0.331558176527555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.03 [0.97-1.1],0.334884998416508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,0.94 [0.84-1.06],0.336300080178861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.97 [0.92-1.03],0.337280311699281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.97 [0.91-1.03],0.337318442473106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,1.04 [0.95-1.14],0.347446475454396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ALCAM,CD166 antigen,Inverse variance weighted,4,1.07 [0.93-1.24],0.347674540468603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.06 [0.94-1.2],0.358454476687471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.91 [0.74-1.12],0.363034022064401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCN3,CCN family member 3,Inverse variance weighted,17,1.02 [0.98-1.07],0.364405882361233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.06 [0.94-1.2],0.366449172194996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LGALS9,Galectin-9,Inverse variance weighted,36,1.02 [0.98-1.05],0.376523615730308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.93 [0.79-1.09],0.378344899152484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,1.08 [0.91-1.28],0.382782957936436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.02 [0.97-1.07],0.383745146958635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.95 [0.86-1.06],0.389657028537606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GAST,Gastrin,Inverse variance weighted,9,1.06 [0.93-1.19],0.389755672811108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.94 [0.83-1.08],0.391159802823192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.95 [0.85-1.07],0.391796963651307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GRN,Progranulin,Inverse variance weighted,46,0.98 [0.95-1.02],0.393433727683329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.09 [0.89-1.34],0.394030692282353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,0.97 [0.9-1.04],0.394942917665789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.07 [0.91-1.27],0.395803387120651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.07 [0.91-1.25],0.398977003948203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.12 [0.86-1.45],0.403644241693573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KLK11,Kallikrein-11,Inverse variance weighted,13,1.04 [0.94-1.15],0.408843156786644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.92 [0.76-1.12],0.410267504374977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,0.99 [0.95-1.02],0.416622046099881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.12 [0.85-1.49],0.4175730779855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPP1,Osteopontin,Inverse variance weighted,13,0.96 [0.86-1.07],0.417966520234187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.94 [0.8-1.1],0.421367154254471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RSPO3,R-spondin-3,Inverse variance weighted,5,0.89 [0.68-1.18],0.424305654102972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CST3,Cystatin-C,Inverse variance weighted,3,0.9 [0.69-1.17],0.427726991173706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,VWC2,Brorin,Inverse variance weighted,12,1.04 [0.95-1.14],0.429880237962279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.07 [0.9-1.28],0.43103918164305,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL6,Interleukin-6,Inverse variance weighted,6,0.98 [0.92-1.04],0.43648767529834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.93 [0.78-1.12],0.439416504740293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.97 [0.91-1.04],0.451395223174495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.03 [0.96-1.1],0.455006210229433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL19,C-C motif chemokine 19,Inverse variance weighted,4,1.16 [0.79-1.69],0.455101267262389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.94 [0.81-1.1],0.461292725273341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,XCL1,Lymphotactin,Inverse variance weighted,15,1.04 [0.94-1.15],0.461846783426999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.99 [0.96-1.02],0.46258018088956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.02 [0.96-1.08],0.465131637387643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.06 [0.9-1.26],0.472047487116383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.91 [0.71-1.17],0.477614011522676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.97 [0.88-1.06],0.479072104814224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,0.98 [0.92-1.04],0.480219989377713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.02 [0.97-1.06],0.481893773471396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.06 [0.91-1.23],0.485956556678605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.98 [0.92-1.04],0.48652020523566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.02 [0.97-1.06],0.489155178332204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.05 [0.91-1.22],0.497893460258446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.96 [0.86-1.08],0.499439601359805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.11 [0.82-1.49],0.500220279203847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,KLK4,Kallikrein-4,Inverse variance weighted,5,0.94 [0.8-1.12],0.501646630708749,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.01 [0.98-1.04],0.502996845606112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,0.98 [0.93-1.04],0.507447420862789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PRELP,Prolargin,Inverse variance weighted,5,1.07 [0.87-1.32],0.508291742799322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.04 [0.93-1.17],0.513021850820042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.98 [0.91-1.05],0.514545091542696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,11,1.04 [0.93-1.17],0.51518662600349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,0.99 [0.96-1.02],0.518928112061464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,1.02 [0.96-1.08],0.520481352253561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.06 [0.89-1.26],0.521959875934144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.96 [0.84-1.09],0.522871886854059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.97 [0.87-1.08],0.52409946331959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,1.02 [0.96-1.09],0.528761952069635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,POF1B,Protein POF1B,Inverse variance weighted,4,0.94 [0.79-1.13],0.532469652006958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.02 [0.97-1.07],0.533907537367933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.04 [0.91-1.19],0.53520527686638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.04 [0.92-1.17],0.536613152593322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.85 [0.52-1.41],0.536731032171243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.99 [0.95-1.03],0.536858605335334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AREG,Amphiregulin,Inverse variance weighted,5,0.96 [0.85-1.09],0.538871175542295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BSG,Basigin,Inverse variance weighted,6,1.06 [0.89-1.26],0.541037458124362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.97 [0.89-1.06],0.541396150829589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NECTIN4,Nectin-4,Inverse variance weighted,4,0.93 [0.74-1.17],0.544263685967775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.93 [0.72-1.19],0.544433432293052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.01 [0.97-1.05],0.545051664302345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TP53BP1,TP53-binding protein 1,Inverse variance weighted,7,1.08 [0.84-1.38],0.555442386627555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,1.02 [0.95-1.1],0.563491817731336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.03 [0.92-1.17],0.580307948304586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,THBD,Thrombomodulin,Inverse variance weighted,11,0.97 [0.87-1.08],0.581177400975879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.97 [0.85-1.1],0.585084135254289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.05 [0.88-1.26],0.590471769759203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.98 [0.92-1.05],0.59163885827143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.05 [0.88-1.26],0.593073609798724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.01 [0.96-1.07],0.593358228694146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SDC1,Syndecan-1,Inverse variance weighted,12,0.98 [0.91-1.05],0.597222113357846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.04 [0.89-1.21],0.600739464079222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.97 [0.86-1.09],0.609266906862787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FBLN2,Fibulin-2,Inverse variance weighted,6,0.97 [0.88-1.08],0.612807623170051,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.98 [0.91-1.06],0.613212970522352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.96 [0.81-1.14],0.626824534702339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.02 [0.94-1.1],0.631115719038261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GUCA2A,Guanylin,Inverse variance weighted,7,1.03 [0.92-1.15],0.632834762176978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.97 [0.84-1.12],0.643225267563748,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.04 [0.89-1.21],0.643782956051049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.02 [0.94-1.1],0.643944646137265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LIPF,Gastric triacylglycerol lipase,Inverse variance weighted,24,0.99 [0.94-1.04],0.644679870239598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD22,B-cell receptor CD22,Inverse variance weighted,25,0.98 [0.89-1.07],0.644745323342811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DPT,Dermatopontin,Inverse variance weighted,4,0.96 [0.82-1.13],0.646555224799898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.98 [0.91-1.06],0.648118326586298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD99,CD99 antigen,Inverse variance weighted,4,1.03 [0.92-1.14],0.649297719482335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,0.96 [0.8-1.15],0.662683529412634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.97 [0.82-1.13],0.664574001038651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.97 [0.83-1.13],0.672132887520064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.98 [0.9-1.07],0.673254447035993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.96 [0.78-1.17],0.674160296020913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.97 [0.82-1.14],0.694304927543993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AGRN,Agrin,Inverse variance weighted,14,0.98 [0.89-1.08],0.697613539203335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.99 [0.95-1.03],0.702371445633114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.97 [0.82-1.14],0.708057841354382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.96 [0.79-1.18],0.709279792636498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.04 [0.85-1.28],0.712822320974927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.01 [0.97-1.04],0.720467840748323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.98 [0.86-1.12],0.733748705516266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.06 [0.77-1.45],0.734553502365657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SCG3,Secretogranin-3,Inverse variance weighted,16,0.98 [0.87-1.1],0.737297098700432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.04 [0.83-1.3],0.743363558048532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PENK,Proenkephalin-A,Inverse variance weighted,15,1.01 [0.96-1.06],0.74344846204544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.03 [0.87-1.2],0.749120715801508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.01 [0.93-1.1],0.762762277495439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ARNT,Aryl hydrocarbon receptor nuclear translocator,Wald ratio,1,1.04 [0.79-1.37],0.768504857412533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.02 [0.88-1.19],0.77535928152724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,WNT9A,Protein Wnt-9a,Wald ratio,1,0.95 [0.65-1.38],0.778258217510251,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,3,1.04 [0.8-1.34],0.778301115857254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAYN,Layilin,Inverse variance weighted,3,1.04 [0.77-1.43],0.781837239419574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.01 [0.94-1.09],0.785843137507913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NECTIN2,Nectin-2,Inverse variance weighted,3,1.03 [0.83-1.28],0.786267312874154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.02 [0.89-1.16],0.788574830570554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.85-1.23],0.791208965921942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.05 [0.72-1.54],0.791657422484478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.04 [0.78-1.39],0.793739740270618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.95 [0.63-1.42],0.794512342280419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RGMB,RGM domain family member B,Inverse variance weighted,5,0.97 [0.8-1.19],0.794538602543113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.02 [0.87-1.19],0.795577341197208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.03 [0.84-1.26],0.799201597320797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.01 [0.94-1.08],0.800798855733046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.01 [0.95-1.07],0.805092191991691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.01 [0.94-1.09],0.808419183609945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.97 [0.75-1.26],0.812118302095578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MDK,Midkine,Inverse variance weighted,14,0.99 [0.89-1.09],0.812337144180582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PTN,Pleiotrophin,Inverse variance weighted,3,1.04 [0.77-1.39],0.815679361932972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.06 [0.65-1.74],0.816100061542777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.03 [0.83-1.27],0.818366045586496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CHGA,Chromogranin-A,Inverse variance weighted,5,1.01 [0.91-1.12],0.823629430702139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.04 [0.7-1.55],0.828689303826733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD302,CD302 antigen,Inverse variance weighted,11,1.01 [0.92-1.11],0.831791365625567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PGF,Placenta growth factor,Inverse variance weighted,5,1.02 [0.85-1.21],0.834770149697586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.01 [0.95-1.07],0.835785958261476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.01 [0.91-1.12],0.837778363643813,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,4,0.98 [0.84-1.16],0.845506368930177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MMP3,Stromelysin-1,Inverse variance weighted,4,1.03 [0.79-1.33],0.846333854304463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,Inverse variance weighted,3,0.99 [0.86-1.13],0.846645288929429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.03 [0.77-1.38],0.854494436330566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.97 [0.68-1.37],0.854544054946896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.02 [0.83-1.24],0.855643069419711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.99 [0.89-1.11],0.859399520600451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1 [0.98-1.03],0.861743766035164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.01 [0.94-1.07],0.863605876516426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.01 [0.9-1.13],0.866695769066915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.98 [0.77-1.25],0.866739430462534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.98 [0.73-1.3],0.870561710999101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.01 [0.9-1.14],0.870777450808379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.98 [0.76-1.26],0.87130118125564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.01 [0.94-1.07],0.874089212749986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD160,CD160 antigen,Inverse variance weighted,24,1.01 [0.94-1.08],0.876064476042313,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1 [0.97-1.03],0.878993915951501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.98 [0.72-1.32],0.881458893780914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MPO,Myeloperoxidase,Inverse variance weighted,17,1 [0.95-1.06],0.881615789958429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.01 [0.92-1.1],0.884571867428376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1 [0.93-1.08],0.905518005658064,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.97-1.03],0.90817040475754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CCN5,CCN family member 5,Inverse variance weighted,12,1 [0.96-1.05],0.909772622545519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.98 [0.66-1.45],0.912456081633963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1 [0.94-1.08],0.917667812524906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,SPON2,Spondin-2,Inverse variance weighted,3,0.99 [0.78-1.25],0.924036661500066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,1 [0.95-1.05],0.924263979430495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.98 [0.64-1.5],0.928785342395323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.01 [0.85-1.19],0.930252376851727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.01 [0.89-1.14],0.932046023303193,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.99 [0.82-1.2],0.935665245911784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.01 [0.83-1.23],0.939681483792375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,UMOD,Uromodulin,Inverse variance weighted,34,1 [0.94-1.06],0.94445283088963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.01 [0.82-1.23],0.94670311152358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.99 [0.8-1.23],0.946900031976146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,REN,Renin,Inverse variance weighted,8,1 [0.86-1.15],0.947564717491934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1 [0.96-1.04],0.950301330849181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.99 [0.83-1.19],0.953640952726576,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1 [0.92-1.09],0.954532650586263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.86-1.16],0.954603150861341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1 [0.93-1.08],0.956767490508009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.01 [0.77-1.32],0.957469414259665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.99 [0.78-1.27],0.960564336726365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1 [0.93-1.07],0.962401626788446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CTSL,Cathepsin L1,Inverse variance weighted,29,1 [0.94-1.06],0.964030742439733,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1 [0.85-1.18],0.969875416937736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1 [0.97-1.03],0.975721236794488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1 [0.81-1.23],0.982595071018817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1 [0.74-1.36],0.991670712642028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1 [0.88-1.13],0.997793220967441,trans
